Subject to change.
Subject to change.
Dawn Cardeiro is a Market Access Strategy Director at Roche Diagnostics, where she develops U.S. strategies to advance patient access to innovative diagnostics. Her career spans over three decades in clinical, advocacy, and commercial roles, including at Point32Health, Myriad Genetics, and Foundation Medicine. She holds a B.S. in Chemistry from Fairfield University and an M.S. in Human Genetics from Sarah Lawrence College.